Strategies for Multivessel Revascularization in Patients with Diabetes
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND In some randomized trials comparing revascularization strategies for patients with diabetes, coronary-artery bypass grafting (CABG) has had a better outcome than percutaneous coronary intervention (PCI). We sought to discover whether aggressive medical therapy and the use of drug-eluting stents could alter the revascularization approach for patients with diabetes and multivessel coronary artery disease. METHODS In this randomized trial, we assigned patients with diabetes and multivessel coronary artery disease to undergo either PCI with drug-eluting stents or CABG. The patients were followed for a minimum of 2 years (median among survivors, 3.8 years). All patients were prescribed currently recommended medical therapies for the control of low-density lipoprotein cholesterol, systolic blood pressure, and glycated hemoglobin. The primary outcome measure was a composite of death from any cause, nonfatal myocardial infarction, or nonfatal stroke. RESULTS From 2005 through 2010, we enrolled 1900 patients at 140 international centers. The patients' mean age was 63.1±9.1 years, 29% were women, and 83% had three-vessel disease. The primary outcome occurred more frequently in the PCI group (P=0.005), with 5-year rates of 26.6% in the PCI group and 18.7% in the CABG group. The benefit of CABG was driven by differences in rates of both myocardial infarction (P<0.001) and death from any cause (P=0.049). Stroke was more frequent in the CABG group, with 5-year rates of 2.4% in t…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Impressively, these results were consistent across all prespecified subgroups.274,275,292”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“(30-day stroke rate for CABG versus PCI, 1.8% versus 0.3%274)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“as did the individual outcomes of death (16.3% versus 10.9%; P<0.05)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“the primary composite outcome of 5-year rates of death resulting from any cause, nonfatal myocardial infarction, or nonfatal stroke occurred more frequently in the PCI group (26.6% versus 18.7%; P=0.005)”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
In the citing paper
“although stroke was more common after CABG (5.2% versus 2.4%; P=0.03).”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [274]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333 · cited 1×
“Of these patients, 25% have diabetes.(1,2) In the Bypass Angioplasty Revascularization Investigation (BARI) trial, patients with diabetes and multivessel disease who underwent coronaryartery bypass grafting (CABG) lived longer than did patients undergoing balloon angioplasty, a finding that led to guideline recommenda…”
BackgroundSerruys, P. W., Morice, M.-C., Kappetein, A. P., Colombo, A., Holmes, D. R., Mack, M. J., Ståhle, E., Feldman, T. E., van den Brand, M., Bass, E. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804626 · Cited by 4,331 · cited 6×
“In this randomized trial, we assigned patients with diabetes and multivessel coronary artery disease to undergo either PCI with drug-eluting stents or CABG.”
ResultInfluentialSelf-citationDeveloped with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI), Authors/Task Force Members, Wijns, W., Kolh, P., Danchin, N., Di Mario, C., Falk, V., Folliguet, T., Garg, S., Huber, K., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq277 · Cited by 3,184
Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis
Rankin, J. (1957) · Scottish Medical Journal · doi:10.1177/003693305700200504 · Cited by 2,506
Self-citationThe SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.
Sianos, G., Morel, M., Kappetein, A. P., Morice, M., Colombo, A., Dawkins, K. D., van den Brand, M., Dyck, N. V., Russell, M. E., Mohr, F. W., et al. (2005) · PubMed · Cited by 2,293
ACC/AHA guidelines for coronary artery bypass graft surgery
Eagle, K. A., Guyton, R. A., Davidoff, R., Ewy, G. A., Fonger, J., Gardner, T. J., Gott, J. P., Herrmann, H. C., Marlow, R. A., Nugent, W. C., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00389-7 · Cited by 1,995
Comparison of Coronary Bypass Surgery with Angioplasty in Patients with Multivessel Disease
(1996) · New England Journal of Medicine · doi:10.1056/nejm199607253350401 · Cited by 1,531
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery
Hillis, L. D., Smith, P. K., Anderson, J. L., Bittl, J. A., Bridges, C. R., Byrne, J. G., Cigarroa, J. E., DiSesa, V. J., Hiratzka, L. F., Hutter, A. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.009 · Cited by 820
Self-citationHlatky, M. A., Boothroyd, D. B., Bravata, D. M., Boersma, E., Booth, J., Brooks, M. M., Carrié, D., Clayton, T. C., Danchin, N., Flather, M., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60552-3 · Cited by 735 · cited 1×
“A comprehensive meta-analysis of trials performed before the introduction of drug-eluting stents showed excess mortality after PCI, as compared with CABG, in patients with diabetes.(20) Although our study was not powered to detect a difference in all-cause mortality, we observed a significantly (P = 0.”
ResultSelf-citationInvestigators, T. B. (1997) · Circulation · doi:10.1161/01.cir.96.6.1761 · Cited by 619
Research works printed but not linked: 1
- Sianos G, 2005, EuroIntervention, 1, 219
Cited by
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
2018 ESC/EACTS guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy394 · Cited by 7,167
Collet, J.-P., Thiele, H., Barbato, E., Barthélémy, O., Bauersachs, J., Bhatt, D. L., Dendale, P., Dorobantu, M., Edvardsen, T., Folliguet, T., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa575 · Cited by 5,037
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
2013 ESC guidelines on the management of stable coronary artery disease
Task Force Members, Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht296 · Cited by 4,510
Self-citation(2014) · European Heart Journal · doi:10.1093/eurheartj/ehu278 · Cited by 4,314
2014 ESC/EACTS Guidelines on myocardial revascularization
Kolh, P., Windecker, S., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., Jüni, P., et al. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu366 · Cited by 4,199
McCrindle, B. W., Rowley, A. H., Newburger, J. W., Burns, J. C., Bolger, A. F., Gewitz, M., Baker, A. L., Jackson, M. A., Takahashi, M., Shah, P. B., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000484 · Cited by 3,723
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.017 · Cited by 3,595
2024 ESC Guidelines for the management of chronic coronary syndromes
Vrints, C., Andreotti, F., Koskinas, K. C., Rossello, X., Adamo, M., Ainslie, J., Banning, A. P., Budaj, A., Buechel, R. R., Chiariello, G. A., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae177 · Cited by 2,774
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,955
Mohr, F. W., Morice, M.-C., Kappetein, A. P., Feldman, T. E., Ståhle, E., Colombo, A., Mack, M. J., Holmes, D. R., Morel, M.-A., Dyck, N. V., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60141-5 · Cited by 1,789
Self-citationVirani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001168 · Cited by 1,598
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
Lawton, J. S., Tamis-Holland, J. E., Bangalore, S., Bates, E. R., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.09.006 · Cited by 1,558
Reed, G. W., Rossi, J. E., & Cannon, C. P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)30677-8 · Cited by 1,507
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
Paneni, F., Beckman, J. A., Creager, M. A., & Cosentino, F. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht149 · Cited by 1,401
Lawton, J. S., Tamis-Holland, J. E., Bangalore, S., Bates, E. R., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001038 · Cited by 829
2018 ESC/EACTS Guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · EuroIntervention · doi:10.4244/eijy19m01_01 · Cited by 1,259
Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association
Mehta, L. S., Beckie, T. M., DeVon, H. A., Grines, C. L., Krumholz, H. M., Johnson, M. N., Lindley, K. J., Vaccarino, V., Wang, T. Y., Watson, K. E., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000351 · Cited by 1,244
“Both a systematic review of 23 published CABG studies that reported data stratified by sex234 and a mandatory registry of 40 000 patients undergoing CABG in California235 showed that women are older and sicker at the time of CABG.”
ResultInfluentialEuropean Society of Cardiology: cardiovascular disease statistics 2021
Timmis, A., Vardas, P., Townsend, N., Torbica, A., Katus, H., De Smedt, D., Gale, C. P., Maggioni, A. P., Petersen, S. E., Huculeci, R., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab892 · Cited by 1,102
Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000134 · Cited by 1,059
Fihn, S. D., Blankenship, J. C., Alexander, K. P., Bittl, J. A., Byrne, J. G., Fletcher, B. J., Fonarow, G. C., Lange, R. A., Levine, G. N., Maddox, T. M., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000095 · Cited by 1,029
2018 ESC/EACTS Guidelines on myocardial revascularization
Sousa-Uva, M., Neumann, F.-J., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezy289 · Cited by 989
Lawton, J. S., Tamis-Holland, J. E., Bangalore, S., Bates, E. R., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001039 · Cited by 641
Farooq, V., van Klaveren, D., Steyerberg, E. W., Meliga, E., Vergouwe, Y., Chieffo, A., Kappetein, A. P., Colombo, A., Holmes, D. R., Mack, M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60108-7 · Cited by 840
Self-citationThe Tissue-Engineered Vascular Graft—Past, Present, and Future
Pashneh-Tala, S., MacNeil, S., & Claeyssens, F. (2016) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2015.0100 · Cited by 798
Drug-Eluting Coronary-Artery Stents
Stefanini, G. G., & Holmes, D. R. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1210816 · Cited by 728
Head, S. J., Milojevic, M., Daemen, J., Ahn, J.-M., Boersma, E., Christiansen, E. H., Domanski, M. J., Farkouh, M. E., Flather, M., Fuster, V., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30423-9 · Cited by 734
Self-citationFihn, S. D., Blankenship, J. C., Alexander, K. P., Bittl, J. A., Byrne, J. G., Fletcher, B. J., Fonarow, G. C., Lange, R. A., Levine, G. N., Maddox, T. M., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.07.017 · Cited by 699
Rao, S. V., O’Donoghue, M. L., Ruel, M., Rab, T., Tamis-Holland, J. E., Alexander, J. H., Baber, U., Baker, H., Cohen, M. G., Cruz-Ruiz, M., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001309 · Cited by 625
(2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.10.013 · Cited by 609
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.04.003 · Cited by 596
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
Rao, S. V., O’Donoghue, M. L., Ruel, M., Rab, T., Tamis-Holland, J. E., Alexander, J. H., Baber, U., Baker, H., Cohen, M. G., Cruz-Ruiz, M., et al. (2025) · JACC · doi:10.1016/j.jacc.2024.11.009 · Cited by 552
Morice, M.-C., Serruys, P. W., Kappetein, A. P., Feldman, T. E., Ståhle, E., Colombo, A., Mack, M. J., Holmes, D. R., Choi, J. W., Ruzyllo, W., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.006689 · Cited by 530
Self-citationPCI and CABG for Treating Stable Coronary Artery Disease
Doenst, T., Haverich, A., Serruys, P., Bonow, R. O., Kappetein, P., Falk, V., Velazquez, E., Diegeler, A., & Sigusch, H. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.053 · Cited by 528
“Because the main mechanism of death is cardiac (7,23,40,41) and perioperative risk appears similar, independent of the SYNTAX score, this finding also suggests that infarct reduction is the main reason for the difference in all-cause mortality.”
BackgroundInfluentialTrial of Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease
Park, S.-J., Ahn, J.-M., Kim, Y.-H., Park, D.-W., Yun, S.-C., Lee, J.-Y., Kang, S.-J., Lee, S.-W., Lee, C. W., Park, S.-W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1415447 · Cited by 505
Self-citationTaqueti, V. R., Hachamovitch, R., Murthy, V. L., Naya, M., Foster, C. R., Hainer, J., Dorbala, S., Blankstein, R., & Di Carli, M. F. (2015) · Circulation · doi:10.1161/circulationaha.114.011939 · Cited by 497
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2015) · Kardiologia Polska · doi:10.5603/kp.2015.0243 · Cited by 458
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II
Beckman, J. A., Paneni, F., Cosentino, F., & Creager, M. A. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht142 · Cited by 434
“8 years.(154) Subjects who underwent surgical bypass had an absolute 7.”
BackgroundFive-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting
Lamy, A., Devereaux, P. J., Prabhakaran, D., Taggart, D. P., Hu, S., Straka, Z., Piegas, L. S., Avezum, A., Akar, A. R., Lanas Zanetti, F., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1601564 · Cited by 432
2014 ESC/EACTS Guidelines on myocardial revascularization
Windecker, S., Kolh, P., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., Jüni, P., et al. (2014) · Kardiologia Polska · doi:10.5603/kp.2014.0224 · Cited by 418
Vascular Complications of Diabetes
Beckman, J. A., & Creager, M. A. (2016) · Circulation Research · doi:10.1161/circresaha.115.306884 · Cited by 412
Type-2 diabetes mellitus and cardiovascular disease
Henning, R. J. (2018) · Future Cardiology · doi:10.2217/fca-2018-0045 · Cited by 398
Kappetein, A. P., Head, S. J., Morice, M.-C., Banning, A. P., Serruys, P. W., Mohr, F.-W., Dawkins, K. D., Mack, M. J., & on behalf of the SYNTAX Investigators (2013) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezt017 · Cited by 394
“In contrast to the results from the FREEDOM trial where there was no treatment-by-SYNTAX Score interaction [19], previous studies found that the SYNTAX Score was a predictor of adverse events”
ResultSelf-citation2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary
Lawton, J. S., Tamis-Holland, J. E., Bangalore, S., Bates, E. R., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.09.005 · Cited by 367
Fractional Flow Reserve–Guided PCI as Compared with Coronary Bypass Surgery
Fearon, W. F., Zimmermann, F. M., De Bruyne, B., Piroth, Z., van Straten, A. H. M., Szekely, L., Davidavičius, G., Kalinauskas, G., Mansour, S., Kharbanda, R., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2112299 · Cited by 359
Head, S. J., Davierwala, P. M., Serruys, P. W., Redwood, S. R., Colombo, A., Mack, M. J., Morice, M.-C., Holmes, D. R., Feldman, T. E., Stahle, E., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu213 · Cited by 361
Self-citationWindecker, S., Stortecky, S., Stefanini, G. G., daCosta, B. R., Rutjes, A. W., Di Nisio, M., Siletta, M. G., Maione, A., Alfonso, F., Clemmensen, P. M., et al. (2014) · BMJ · doi:10.1136/bmj.g3859 · Cited by 356
Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease
Ahn, J.-M., Roh, J.-H., Kim, Y.-H., Park, D.-W., Yun, S.-C., Lee, P. H., Chang, M., Park, H. W., Lee, S.-W., Lee, C. W., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.03.033 · Cited by 352
“Unlike the situation in multivessel disease (21,22), both revascularization treatment showed the similar rate of the composite of death, myocardial infarction or stroke in patients with ULMCA stenosis.”
Background2014 ESC/EACTS Guidelines on myocardial revascularization
Windecker, S., Kolh, P., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., Jüni, P., et al. (2015) · EuroIntervention · doi:10.4244/eijy14m09_01 · Cited by 328
Coronary Artery Disease in Patients ≥80 Years of Age
Madhavan, M. V., Gersh, B. J., Alexander, K. P., Granger, C. B., & Stone, G. W. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.12.068 · Cited by 320
Self-citationEuropean Society of Cardiology: the 2023 Atlas of Cardiovascular Disease Statistics
Timmis, A., Aboyans, V., Vardas, P., Townsend, N., Torbica, A., Kavousi, M., Boriani, G., Huculeci, R., Kazakiewicz, D., Scherr, D., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae466 · Cited by 314
Coronary stents: historical development, current status and future directions
Iqbal, J., Gunn, J., & Serruys, P. W. (2013) · British Medical Bulletin · doi:10.1093/bmb/ldt009 · Cited by 319
Current Status of Rotational Atherectomy
Tomey, M. I., Kini, A. S., & Sharma, S. K. (2014) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2013.12.196 · Cited by 312
Arnold, S. V., Bhatt, D. L., Barsness, G. W., Beatty, A. L., Deedwania, P. C., Inzucchi, S. E., Kosiborod, M., Leiter, L. A., Lipska, K. J., Newman, J. D., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000766 · Cited by 304
Fifty years of coronary artery bypass grafting
Melly, L., Torregrossa, G., Lee, T., Jansens, J.-L., & Puskas, J. D. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.02.43 · Cited by 301
“CABG compared to PCI in terms of survival rates (65-67).”
MethodHeart failure: a cardiovascular outcome in diabetes that can no longer be ignored
McMurray, J. J. V., Gerstein, H. C., Holman, R. R., & Pfeffer, M. A. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70031-2 · Cited by 304
Taqueti, V. R., Shaw, L. J., Cook, N. R., Murthy, V. L., Shah, N. R., Foster, C. R., Hainer, J., Blankstein, R., Dorbala, S., & Di Carli, M. F. (2017) · Circulation · doi:10.1161/circulationaha.116.023266 · Cited by 299
Samano, N., Geijer, H., Liden, M., Fremes, S., Bodin, L., & Souza, D. (2015) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2015.07.027 · Cited by 297
Escaned, J., Collet, C., Ryan, N., Luigi De Maria, G., Walsh, S., Sabate, M., Davies, J., Lesiak, M., Moreno, R., Cruz-Gonzalez, I., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx512 · Cited by 294
“Subsequently, the superiority of CABG over PCI, with firstgeneration DES, was confirmed in patients with diabetes in the FREEDOM trial.(3) Recently, in the BEST trial, comparing CABG with PCI in 3VD using newer generation DES, the 5-year clinical outcomes were inferior amongst patients who underwent PCI.”
ResultCoronary-Artery Bypass Grafting
Alexander, J. H., & Smith, P. K. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1406944 · Cited by 280
Kedhi, E., Berta, B., Roleder, T., Hermanides, R. S., Fabris, E., IJsselmuiden, A. J. J., Kauer, F., Alfonso, F., von Birgelen, C., Escaned, J., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab433 · Cited by 288
Volatile Anesthetics versus Total Intravenous Anesthesia for Cardiac Surgery
Landoni, G., Lomivorotov, V. V., Nigro Neto, C., Monaco, F., Pasyuga, V. V., Bradic, N., Lembo, R., Gazivoda, G., Likhvantsev, V. V., Lei, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1816476 · Cited by 279
The growth of acute kidney injury: a rising tide or just closer attention to detail?
Siew, E. D., & Davenport, A. (2015) · Kidney International · doi:10.1038/ki.2014.293 · Cited by 275
“77, 78 In an attempt to quantify the potential impact of some of the above-mentioned factors on the growth of AKI, Hsu et al. 32 used regression modeling to study patient-level data that might explain continued growth in the incidence of dialysis-requiring AKI observed through 2009 within the NIS.”
Deb, S., Wijeysundera, H. C., Ko, D. T., Tsubota, H., Hill, S., & Fremes, S. E. (2013) · JAMA · doi:10.1001/jama.2013.281718 · Cited by 277
Goel, S. S., Ige, M., Tuzcu, E. M., Ellis, S. G., Stewart, W. J., Svensson, L. G., Lytle, B. W., & Kapadia, S. R. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.096 · Cited by 274
“In patients with severe left main disease or 3-vessel CAD, particularly in those with diabetes mellitus, outcomes after CABG have been shown to be superior to PCI (50,51).”
BackgroundLong-Term Survival Following Multivessel Revascularization in Patients With Diabetes
Farkouh, M. E., Domanski, M., Dangas, G. D., Godoy, L. C., Mack, M. J., Siami, F. S., Hamza, T. H., Shah, B., Stefanini, G. G., Sidhu, M. S., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.001 · Cited by 268
“The FREEDOM (Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease) trial (1) demonstrated that, in patients with diabetes mellitus (DM) and multivessel coronary disease (MVD), coronary artery bypass graft (CABG) surgery is associated with a reduction in majo…”
BackgroundSelf-citationSaphenous vein grafts in contemporary coronary artery bypass graft surgery
Caliskan, E., de Souza, D. R., Böning, A., Liakopoulos, O. J., Choi, Y.-H., Pepper, J., Gibson, C. M., Perrault, L. P., Wolf, R. K., Kim, K.-B., et al. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0249-3 · Cited by 265
Diabetes and Cardiovascular Disease in Older Adults: Current Status and Future Directions
Halter, J. B., Musi, N., McFarland Horne, F., Crandall, J. P., Goldberg, A., Harkless, L., Hazzard, W. R., Huang, E. S., Kirkman, M. S., Plutzky, J., et al. (2014) · Diabetes · doi:10.2337/db14-0020 · Cited by 255
Kirtane, A. J., Doshi, D., Leon, M. B., Lasala, J. M., Ohman, E. M., O’Neill, W. W., Shroff, A., Cohen, M. G., Palacios, I. F., Beohar, N., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.022061 · Cited by 249
Self-citationStone, P. H., Libby, P., & Boden, W. E. (2023) · JAMA Cardiology · doi:10.1001/jamacardio.2022.3926 · Cited by 242
Myocardial ischemia and coronary disease in heart failure
Pagliaro, B. R., Cannata, F., Stefanini, G. G., & Bolognese, L. (2020) · Heart Failure Reviews · doi:10.1007/s10741-019-09831-z · Cited by 242
Coronary Artery Bypass Grafting With and Without Manipulation of the Ascending Aorta
Zhao, D. F., Edelman, J. J., Seco, M., Bannon, P. G., Wilson, M. K., Byrom, M. J., Thourani, V., Lamy, A., Taggart, D. P., Puskas, J. D., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.071 · Cited by 243
“These results are also supported by the FREEDOM (Strategies for Multivessel Revascularization in Patients with Diabetes) trial in a population of diabetic patients (2).”
ResultSipahi, I., Akay, M. H., Dagdelen, S., Blitz, A., & Alhan, C. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12844 · Cited by 239
The Task Force on diabetes, P.-D. (2014) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114525548 · Cited by 236
Epidemiology of Coronary Artery Disease
Duggan, J. P., Peters, A. S., Trachiotis, G. D., & Antevil, J. L. (2022) · Surgical Clinics of North America · doi:10.1016/j.suc.2022.01.007 · Cited by 231
Why is the mammary artery so special and what protects it from atherosclerosis?
Otsuka, F., Yahagi, K., Sakakura, K., & Virmani, R. (2013) · PubMed · doi:10.3978/j.issn.2225-319x.2013.07.06 · Cited by 210
Current Practice of State-of-the-Art Surgical Coronary Revascularization
Head, S. J., Milojevic, M., Taggart, D. P., & Puskas, J. D. (2017) · Circulation · doi:10.1161/circulationaha.116.022572 · Cited by 224
Coronary Artery Disease and Diabetes Mellitus
Aronson, D., & Edelman, E. R. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2014.04.001 · Cited by 222
Verma, S., Farkouh, M. E., Yanagawa, B., Fitchett, D. H., Ahsan, M. R., Ruel, M., Sud, S., Gupta, M., Singh, S., Gupta, N., et al. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70089-5 · Cited by 216
Self-citationDefining an Intraoperative Hypotension Threshold in Association with Stroke in Cardiac Surgery
Sun, L. Y., Chung, A. M., Farkouh, M. E., van Diepen, S., Weinberger, J., Bourke, M., & Ruel, M. (2018) · Anesthesiology · doi:10.1097/aln.0000000000002298 · Cited by 207
Self-citationTakahashi, K., Serruys, P. W., Fuster, V., Farkouh, M. E., Spertus, J. A., Cohen, D. J., Park, S.-J., Park, D.-W., Ahn, J.-M., Kappetein, A. P., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32114-0 · Cited by 204
Self-citationStable coronary artery disease: revascularisation and invasive strategies
Piccolo, R., Giustino, G., Mehran, R., & Windecker, S. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61220-x · Cited by 199
Sun, L. Y., Gaudino, M., Chen, R. J., Bader Eddeen, A., & Ruel, M. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.0239 · Cited by 195
From Detecting the Vulnerable Plaque to Managing the Vulnerable Patient
Arbab-Zadeh, A., & Fuster, V. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.07.062 · Cited by 183
Self-citationTrends in Cause of Death After Percutaneous Coronary Intervention
Spoon, D. B., Psaltis, P. J., Singh, M., Holmes, D. R., Gersh, B. J., Rihal, C. S., Lennon, R. J., Moussa, I. D., Simari, R. D., & Gulati, R. (2014) · Circulation · doi:10.1161/circulationaha.113.006518 · Cited by 184
Self-citationNaito, R., & Miyauchi, K. (2017) · International Heart Journal · doi:10.1536/ihj.17-191 · Cited by 172
Abdallah, M. S. (2013) · JAMA · doi:10.1001/jama.2013.279208 · Cited by 169
Coronary artery bypass grafting: Part 1--the evolution over the first 50 years
Head, S. J., Kieser, T. M., Falk, V., Huysmans, H. A., & Kappetein, A. P. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht330 · Cited by 166
“or early postoperative stroke, which are predominantly ischaemic in nature.(195,196) Other important complications are postoperative MI or injury, renal failure, delirium, deep sternal wound infection,”
BackgroundMancini, G. B. J., Gosselin, G., Chow, B., Kostuk, W., Stone, J., Yvorchuk, K. J., Abramson, B. L., Cartier, R., Huckell, V., Tardif, J.-C., et al. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.05.013 · Cited by 166
Self-citationWolff, G., Dimitroulis, D., Andreotti, F., Kołodziejczak, M., Jung, C., Scicchitano, P., Devito, F., Zito, A., Occhipinti, M., Castiglioni, B., et al. (2017) · Circulation: Heart Failure · doi:10.1161/circheartfailure.116.003255 · Cited by 164
Frailty and pre-frailty in cardiac surgery: a systematic review and meta-analysis of 66,448 patients
Lee, J. A., Yanagawa, B., An, K. R., Arora, R. C., Verma, S., Friedrich, J. O., & on behalf of the Canadian Cardiovascular Surgery Meta-Analysis Working Group (2021) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-021-01541-8 · Cited by 180
“Despite the growing proportion of frail patients undergoing cardiac surgery, this vulnerable patient population is often excluded from most prospective surgical trials [7, 8].”
BackgroundGuideline Development Group., Bilo, H. J. G., Coentrão, L., Couchoud, C., Covic, A. C., SUTTER, J. D., Drechsler, C., Gnudi, L., Goldsmith, D. J. A., Heaf, J. G., et al. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv100 · Cited by 189
Long-Term Outcome of PCI Versus CABG in Insulin and Non–Insulin-Treated Diabetic Patients
Dangas, G., Farkouh, M. E., Sleeper, L. A., YANG, M. H., Schoos, M. M., Macaya, C., Abizaid, A., Buller, C. E. H., Devlin, G. P., Rodríguez, A. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.06.1182 · Cited by 149
“Recently, the FREEDOM (Comparison of Two Treatments for Multivessel Coronary Artery Disease in Individuals With Diabetes) trial demonstrated that for patients with diabetes and MVD, CABG is superior to PCI with drug-eluting stents (DES) in that it significantly reduced rates of death and myocardial infarction (MI), al…”
BackgroundMethodSelf-citationStroke Rates Following Surgical Versus Percutaneous Coronary Revascularization
Head, S. J., Milojevic, M., Daemen, J., Ahn, J., Boersma, E. H., Christiansen, E. H., DOMANSKI, M. J., Farkouh, M. E., Flather, M. D., Fuster, V., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.071 · Cited by 145
Self-citationPrediction of Coronary Risk by SYNTAX and Derived Scores
Yadav, M., Palmerini, T., Caixeta, A. M., Madhavan, M. V., Sanidas, E. A., Kirtane, A. J., Stone, G. W., & Généreux, P. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.06.047 · Cited by 145
Waldo, S. W., Secemsky, E. A., O’Brien, C., Kennedy, K. F., Pomerantsev, E. V., Sundt, T. M., McNulty, E. J., Scirica, B. M., & Yeh, R. W. (2014) · Circulation · doi:10.1161/circulationaha.114.011541 · Cited by 144
“001 Coronary Intervention Vessels, n (%) Left Main 47 (22) 39 (5) <0.”
InfluentialThe Primary Outcome Is Positive — Is That Good Enough?
Pocock, S. J., & Stone, G. W. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1601511 · Cited by 142
Spadaccio, C., & Benedetto, U. (2018) · Annals of Cardiothoracic Surgery · doi:10.21037/acs.2018.05.17 · Cited by 141
CHAITMAN, B. R., Alexander, K. P., Cyr, D. D., Berger, J. S., Reynolds, H. R., Bangalore, S., Boden, W. E., Lópes, R. D., Demkow, M., Perna, G. P., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.047987 · Cited by 148
Metadata
- Authors
- Farkouh, M. E., Domanski, M., Sleeper, L. A., Siami, F. S., Dangas, G., Mack, M., Yang, M., Cohen, D. J., Rosenberg, Y., Solomon, S. D., Desai, A. S., Gersh, B. J., Magnuson, E. A., Lansky, A., Boineau, R., Weinberger, J., Ramanathan, K., Sousa, J. E., Rankin, J., Bhargava, B., Buse, J., Hueb, W., Smith, C. R., Muratov, V., Bansilal, S., King, S., Bertrand, M., & Fuster, V.
- Affiliations
- University of Toronto (CA)
- Icahn School of Medicine at Mount Sinai (US)
- New England Research Institutes (US)
- Cardiovascular Research Foundation (US)
- Baylor University Medical Center (US)
- University of Missouri–Kansas City (US)
- National Heart, Lung, and Blood Institute (US)
- Brigham and Women's Hospital (US)
- Mayo Clinic (US)
- Yale University (US)
- University of British Columbia (CA)
- Instituto Dante Pazzanese de Cardiologia (BR)
- Royal Perth Hospital (AU)
- All India Institute of Medical Sciences (IN)
- University of North Carolina at Chapel Hill (US)
- Universidade de São Paulo (BR)
- NewYork–Presbyterian Hospital (US)
- Université de Lille (FR)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-12-20
- Volume
- 367
- Issue
- 25
- Pages
- 2375-2384
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1946152282
- Cited by
- 1,922
- References
- 28
- Citations by year
- 2026: 75 · 2025: 85 · 2024: 75 · 2023: 97 · 2022: 132 · 2021: 127 · 2020: 130 · 2019: 120 · 2018: 135 · 2017: 150 · 2016: 182 · 2015: 201 · 2014: 207 · 2013: 181 · 2012: 17
- FWCI
- 196.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- Locations
- New England Journal of Medicine (publishedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Scientific Electronic Library Online (São Paulo Research Foundation, Latin American and Caribbean Center on Health Sciences Information, Conselho Nacional de Desenvolvimento Científico e Tecnológico) (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Edwards Lifesciences
- Boston Scientific Corporation
- Insulet Corporation
- Halozyme
- Medicines Company
- Novo Nordisk
- Genentech
- St. Jude Medical
- Abbott Vascular
- National Heart, Lung, and Blood Institute (U01 01HL071988, R01HL092989, U01HL071988, U01 01HL092989, 01HL092989, 01HL071988)
- Daiichi Sankyo Europe
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Keywords
- multivessel coronary artery disease, diabetes mellitus, coronary artery bypass grafting, percutaneous coronary intervention, drug-eluting stents, revascularization strategy, myocardial infarction, stroke, all-cause mortality, FREEDOM trial
- MeSH terms
- Aged, Coronary Artery Bypass, Cardiovascular Diseases, Coronary Artery Disease, Female, Humans, Male, Middle Aged, Myocardial Infarction, Angioplasty, Balloon, Coronary, Stroke, Diabetes Complications, Kaplan-Meier Estimate, Drug-Eluting Stents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.